Chet Rao and Don Kremin from Hormel Health Labs join Lunch Break and discuss how the company has joined several of the world’s top cancer institutions to develop meals and shakes to meet the nutritional needs and tastes of cancer patients.
There are 18 million cancer patients going through therapy right now, and that number increases by 2 million or so annually. After combating illness, the biggest challenge they face is nutrition. So Hormel Foods decided to do something about it, and found itself inventing a new customer segment.
The Specialty Foods division of Hormel Foods Corporation (NYSE: HRL) has partnered with the Cancer Nutrition Consortium, to provide cancer patients with nutritional offerings for their specific, individual needs during cancer treatment.